Altered expression of the lymphocyte activation antigen CD30 in active celiac disease

Abstract

Interleukin (IL)-15 and CD30 may be associated with the ongoing intestinal immunologic activation in celiac disease (CD). We studied duodenal biopsies and blood samples of patients with active CD (Cel) and controls in order to determine the regulatory role proposed for CD30⁺ T cells in this Th1-driven disease and the potential influences of IL-15 on CD30 expression. We detected that a CD30⁺ T-cell subpopulation persists longer in Cel after a 5 day incubation with anti-CD3 antibody than in controls (p = 0.0063). CD30 upregulation by IL-15 in T blasts was greater in Cel than in controls (p = 0.0062). At the mucosal compartment, the CD30 antigen was examined by immunohistochemistry and quantified on isolated lamina propria (LP) and epithelial T cells by flow cytometry. For Cel and controls, similar mean percentages of CD3⁺CD30⁺ intraepithelial T cells (5.88 vs. 5.51, p = ns) and LP T cells (7.38 vs. 7.49, p = ns) were observed at baseline and after in vitro gliadin challenge of duodenal biopsy samples. Our study demonstrates the occurrence of potentially important alterations of the immune response at the peripheral compartment. Our findings also allow us to speculate that a negative effect of soluble mediators at the mucosal compartment might counteract the latent influence of IL-15 on CD30 expression precluding a more severe course of active CD.

Keywords::

• Active celiac disease
• CD30 antigen
• peripheral blood
• small intestine mucosa
• interleukin-15

Acknowledgements

We wish to thank the patients and their families for their cooperation and blood samples.Declaration of interest: This study was funded by the Buenos Aires University (M010), CONICET (PIP 6104), ANPCyT (06-257), and Fundación Carolina and Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.